Pharmabiz3h
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset: Our Bureau, Bengaluru Wednesday, March ...
Pharmabiz3h
HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts
HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts: Our Bureau, Bengaluru Wednesday, March ...
Pharmabiz36m
AiMeD urges govt to prioritize healthcare security through balanced tariff measures for medical devices
AiMeD urges govt to prioritize healthcare security through balanced tariff measures for medical devices: Our Bureau, New Delhi Wednesday, March 19, 2025, 15:15 Hrs [IST] The Assoc ...
Pharmabiz50m
Medit introduces Medit SmartX, a new All-on-X solution
Medit, a global leader in digital dentistry, has launched its latest All-on-X solution, Medit SmartX. This innovative solution empowers implant clinicians to fully leverage the potential of the ...
Pharmabiz1h
US FDA grants Fast Track designation to Johnson & Johnson’s nipocalimab to treat adult patients with moderate-to-severe Sjögren’s disease
Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...
Pharmabiz1h
Irish medtech leader Aerogen opens India headquarters in the National Capital Territory of Delhi
Irish medtech leader Aerogen opens India headquarters in the National Capital Territory of Delhi: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:30 Hrs [IST] Aerogen, the Ire ...
Pharmabiz2h
Cellogen Therapeutics gets DCGI nod to develop indigenous Bi-Specific 3rd Generation CAR T cells for cancer
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
Pharmabiz1h
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:45 Hrs [IST] Sovereign Pharma, ...
Pharmabiz2h
Oncorena receives US FDA approval to initiate studies in US
Oncorena, a Swedish pharma company, announced that the US FDA has approved the company’s IND application to initiate the phase I/II study Oncorella-1: A phase 1/2, open label, single arm study on ...
Pharmabiz3h
USV launches empagliflozin and its combinations for diabetes care in India
USV launches empagliflozin and its combinations for diabetes care in India: Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:40 Hrs [IST] USV, an Indian multinational healthcar ...
Pharmabiz3h
Sartorius India to invest in capacity expansion to serve global bioprocessing market with pallet tanks for single-use bioreactors
Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:30 Hrs [IST] ...
Pharmabiz4h
Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882
Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...